Predictive Oncology Inc. announced the completion of its registered direct offering, selling 363,336 shares of common stock at $1.50 per share, resulting in gross proceeds of approximately $545,004. H ...
PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), a leader in AI-driven drug discovery and biologics, today closed its ...
PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI) (“Predictive Oncology” or the “Company”), a leader in AI-driven drug discovery and biologics, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results